Sex hormone binding globulin and sex steroids among premenopausal women in the Diabetes Prevention Program

Minority Diabetes Reports Thursday, May 30th, 2013

JCEM: May 24, 2013

Context It is unknown whether intensive lifestyle modification (ILS) or metformin change sex steroids among premenopausal women without a history of polycystic ovarian syndrome (PCOS).

Objectives To examine one-year intervention impact upon sex steroids (estradiol, testosterone, dehydroepiandrosterone, and androstenedione [A4]) and sex hormone binding globulin (SHBG) and differences by race/ethnicity

Participants A subgroup of Diabetes Prevention Program (DPP) participants who were premenopausal, not using estrogen, without a history of PCOS or irregular menses, and who reported non-Hispanic white (NHW), Hispanic, or African-American race/ethnicity (n=301).  Read more

Be Sociable, Share!
National Minority Quality Forum Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2012 National Minority Quality Forum, Inc. All Rights Reserved.